
Sign up to save your podcasts
Or


We discuss the use of the newly approved Susvimo system for sustained delivery of ranibizumab in the treatment of neovascular AMD with Carl Regillo, MD, Professor of Ophthalmology Thomas Jefferson University and Director of the Retina Service at the Wills Eye Hospital.
By Retina Synthesis4.5
88 ratings
We discuss the use of the newly approved Susvimo system for sustained delivery of ranibizumab in the treatment of neovascular AMD with Carl Regillo, MD, Professor of Ophthalmology Thomas Jefferson University and Director of the Retina Service at the Wills Eye Hospital.

43 Listeners

18 Listeners

99 Listeners

113,168 Listeners

56,921 Listeners

5 Listeners

9,558 Listeners

12 Listeners

47,696 Listeners

51 Listeners

11 Listeners

467 Listeners

19 Listeners

0 Listeners